MedTrace Logo

Evaluation of the Impact of Taking American Ginseng for 8 Weeks on Fatigue in Patients Treated for Localized Breast or Gynecological Cancer

NCT05241405 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 354

Last updated 2024-10-01

No results posted yet for this study

Summary

This is a multicenter randomized trial in breast cancer patients reporting cancer-related fatigue to evaluate the efficacy and safety of Qiseng® based on extract of American ginseng combined with vitamin C from extract of Camu Camu berries

Conditions

Interventions

DIETARY_SUPPLEMENT

QISENG

2 capsules/day for 8 weeks.

DIETARY_SUPPLEMENT

PLACEBO

2 capsules/day for 8 weeks.

Sponsors & Collaborators

  • NATSUCA laboratory

    collaborator UNKNOWN

  • Groupement Interrégional de Recherche Clinique et d'Innovation

    collaborator OTHER

  • Centre Francois Baclesse

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-27
Primary Completion
2027-09-30
Completion
2027-09-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05241405 on ClinicalTrials.gov